1. Clinical Overview
L-Carnitine is a conditionally essential amino-acid derivative required for transport of long-chain fatty acids into the mitochondrial matrix for β-oxidation and ATP production. At 600 mg/mL, LC-600 delivers clinically meaningful doses in low injection volumes, improving compliance and protocol efficiency.
2. Mechanisms of Action
2.1 Mitochondrial Fatty Acid Transport
Shuttles long-chain fatty acids across mitochondrial membrane, enables β-oxidation, prevents cytosolic fatty acid accumulation. Improved fat utilization and energy production.
2.2 ATP Production & Energy
Enhanced ATP generation, reduced reliance on glycolysis, improved metabolic flexibility. Greater stamina, endurance, reduced fatigue.
2.3 Metabolic Fatigue & Lactate Reduction
Reduced lactate buildup, improved recovery, enhanced ammonia clearance.
2.4 Insulin Sensitivity & Glucose Handling
Improved skeletal muscle glucose uptake, insulin signaling efficiency, metabolic adaptability during caloric restriction.
2.5 Neurocognitive & Mood Support
Neuronal energy metabolism, cognitive clarity, mood stability, mental fatigue reduction.
3. Evidence-Based Applications
3.1 Weight Loss & Body Composition
Fat oxidation, lean mass preservation, improved metabolic rate. Used alongside GLP-1 agonists, LC-series blends, caloric-deficit programs.
3.2 Exercise Performance & Recovery
Improved endurance, faster post-exercise recovery, reduced muscle soreness.
3.3 Chronic Fatigue & Low Energy
Chronic fatigue patterns, post-viral fatigue, mitochondrial dysfunction, burnout syndromes.
3.4 Metabolic Syndrome & Insulin Resistance
Glucose utilization, fat metabolism, improved metabolic markers.
3.5 Male Fertility & Androgen Support
Sperm motility, testicular mitochondrial function, hormonal health (indirect, adjunctive).
4. Administration & Dosing
No reconstitution required — pre-mixed 600 mg/mL liquid formulation
Weight Loss / Fat Oxidation: 1,000–2,000 mg, 1–3×/week
Performance / Athletic: 1,000–2,000 mg pre/post training, 1–3×/week
Chronic Fatigue / Mito Support: 500–1,000 mg, 2×/week
Duration: 6–12 weeks, may extend or repeat
Injection Volume Reference
| Dose | Volume |
|---|---|
| 300 mg | 0.5 mL |
| 600 mg | 1.0 mL |
| 1,200 mg | 2.0 mL |
| 1,800 mg | 3.0 mL |
| 2,400 mg | 4.0 mL |
Large volumes may be split between injection sites.
5. Clinical Decision Trees
Decision Tree 1 — Candidate Selection
Fatigue or low energy? → Yes
Difficulty losing fat? → Yes
Poor exercise recovery? → Yes
Insulin resistance? → Consider
Severe renal disease? → Avoid or reduce dose
Decision Tree 2 — Dose Selection
General wellness → 500–1,000 mg weekly
Weight loss → 1,000–2,000 mg weekly
Performance → 1,000–2,000 mg pre/post training
Fatigue syndromes → 500–1,000 mg 2×/week
6. Safety, Contraindications & Monitoring
Contraindications
- Severe renal impairment
- Known hypersensitivity
- Pregnancy or lactation (precautionary)
Side Effects
Typically mild/dose-dependent: injection-site discomfort, mild nausea, fishy body odor (rare, high doses), headache, restlessness.
Monitoring
- Energy levels
- Exercise tolerance
- Body composition
- Blood pressure
- Renal function (long-term high-dose)
Legal Disclaimer
This document is provided solely for educational and informational purposes. LC-600 is a compounded nutrient-based formulation not FDA-approved for weight loss or metabolic treatment. Peptide Protocol Portal makes no representations or warranties. By using this document, the reader agrees that Peptide Protocol Portal shall not be held liable. Use at your own risk.
References — LC-600 Clinical Reference Guide
Provider Access Required
Create a provider account to read the full clinical guide for LC-600 L-Carnitine 600 mg/mL.